CCNA1 and breast cancer: As tamoxifen inhibits E2 effect in ER-α positive breast cancer cells by interfering ER-α, we then examined the effect of E2 and tamoxifin combination treatment on MCF-7 cells transfected with cyclin A1-pCMS-EGFP or pCMS-EGFP.